| Ruth Brown, | |
|
1501 Pascagoula St, Pascagoula, MS 39567-6533 | |
| (662) 523-5294 | |
| Not Available |
| Full Name | Ruth Brown |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 4 Years |
| Location | 1501 Pascagoula St, Pascagoula, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770171886 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 1-175264 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mobile Infirmary Medical Center | Mobile, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesiologists Associated Pc | 6204739519 | 361 |
News Archive
A study based on medical records from more than a quarter million adult patients found that African-American patients with connective tissue diseases such as lupus or rheumatoid arthritis were twice as likely as white patients to suffer from narrowed or atherosclerotic blood vessels, which increase the risk of a heart attack, stroke or death.
A new study has found that endoscopic ultrasound (EUS) is associated with improved outcomes in patients with localized pancreatic cancer, possibly due to the detection of earlier cancers and improved stage-appropriate management, including more selective performance of curative intent surgery. This is the first study to analyze a large population-based cancer registry and demonstrate that EUS evaluation is associated with improved pancreatic cancer survival.
Depomed, Inc. today announced that US FDA has approved GRALISE (gabapentin) Tablets for once-daily treatment of post-herpetic neuralgia, which is pain following healing of the rash associated with shingles.
In a late-stage clinical trial, Hodgkin lymphoma (HL) patients who received brentuximab vedotin (BV) post-transplant lived longer without disease progression than patients who received only supportive care. This is the first time a study has demonstrated that adding a maintenance therapy after transplant can improve outcomes.
Effective January 1, 2012, Wisconsin Heart & Vascular Institute will join Meriter Medical Group. The practice, which includes 16 cardiologists, vascular surgeons and mid-level providers who are highly trained specialists with experience in all areas of cardiovascular care, will be renamed Meriter Wisconsin Heart. Meriter Medical Group will thus have grown from 68 providers to 116 in less than 2 years, an increase of 71%.
› Verified 6 days ago
| Entity Name | Anesthesiologists Associated Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851371850 PECOS PAC ID: 6204739519 Enrollment ID: O20040202000465 |
News Archive
A study based on medical records from more than a quarter million adult patients found that African-American patients with connective tissue diseases such as lupus or rheumatoid arthritis were twice as likely as white patients to suffer from narrowed or atherosclerotic blood vessels, which increase the risk of a heart attack, stroke or death.
A new study has found that endoscopic ultrasound (EUS) is associated with improved outcomes in patients with localized pancreatic cancer, possibly due to the detection of earlier cancers and improved stage-appropriate management, including more selective performance of curative intent surgery. This is the first study to analyze a large population-based cancer registry and demonstrate that EUS evaluation is associated with improved pancreatic cancer survival.
Depomed, Inc. today announced that US FDA has approved GRALISE (gabapentin) Tablets for once-daily treatment of post-herpetic neuralgia, which is pain following healing of the rash associated with shingles.
In a late-stage clinical trial, Hodgkin lymphoma (HL) patients who received brentuximab vedotin (BV) post-transplant lived longer without disease progression than patients who received only supportive care. This is the first time a study has demonstrated that adding a maintenance therapy after transplant can improve outcomes.
Effective January 1, 2012, Wisconsin Heart & Vascular Institute will join Meriter Medical Group. The practice, which includes 16 cardiologists, vascular surgeons and mid-level providers who are highly trained specialists with experience in all areas of cardiovascular care, will be renamed Meriter Wisconsin Heart. Meriter Medical Group will thus have grown from 68 providers to 116 in less than 2 years, an increase of 71%.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ruth Brown, 1501 Pascagoula St, Pascagoula, MS 39567-6533 Ph: (662) 523-5294 | Ruth Brown, 1501 Pascagoula St, Pascagoula, MS 39567-6533 Ph: (662) 523-5294 |
News Archive
A study based on medical records from more than a quarter million adult patients found that African-American patients with connective tissue diseases such as lupus or rheumatoid arthritis were twice as likely as white patients to suffer from narrowed or atherosclerotic blood vessels, which increase the risk of a heart attack, stroke or death.
A new study has found that endoscopic ultrasound (EUS) is associated with improved outcomes in patients with localized pancreatic cancer, possibly due to the detection of earlier cancers and improved stage-appropriate management, including more selective performance of curative intent surgery. This is the first study to analyze a large population-based cancer registry and demonstrate that EUS evaluation is associated with improved pancreatic cancer survival.
Depomed, Inc. today announced that US FDA has approved GRALISE (gabapentin) Tablets for once-daily treatment of post-herpetic neuralgia, which is pain following healing of the rash associated with shingles.
In a late-stage clinical trial, Hodgkin lymphoma (HL) patients who received brentuximab vedotin (BV) post-transplant lived longer without disease progression than patients who received only supportive care. This is the first time a study has demonstrated that adding a maintenance therapy after transplant can improve outcomes.
Effective January 1, 2012, Wisconsin Heart & Vascular Institute will join Meriter Medical Group. The practice, which includes 16 cardiologists, vascular surgeons and mid-level providers who are highly trained specialists with experience in all areas of cardiovascular care, will be renamed Meriter Wisconsin Heart. Meriter Medical Group will thus have grown from 68 providers to 116 in less than 2 years, an increase of 71%.
› Verified 6 days ago
Amanda Graham Dobbins, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-806-4525 | |
Mr. Laird Miller, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 | |
Andrew J Zielinski, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5540 Fax: 228-809-1153 | |
Mr. Christopher Arlen Jones, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5531 Fax: 228-809-1153 | |
Jonathan White, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 | |
Mrs. Christine Cooper Bowman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 | |
Robert Shotlander, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 |